SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-057996
Filing Date
2022-02-28
Accepted
2022-02-28 16:30:59
Documents
12
Period of Report
2022-02-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d254354d8k.htm   iXBRL 8-K 32005
  Complete submission text file 0001193125-22-057996.txt   153811

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20220222.xsd EX-101.SCH 2871
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20220222_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20220222_pre.xml EX-101.PRE 11271
6 EXTRACTED XBRL INSTANCE DOCUMENT d254354d8k_htm.xml XML 3349
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 22690208
SIC: 2834 Pharmaceutical Preparations